Opioids during anesthesia in liver and renal failure;Opioide in der anästhesie bei leber- und niereninsuffizienz

Anaesthesist

Volumn 53, Issue 3, 2004, Pages 291-303

  Hohne C ^a   Donaubauer, B ^a   Kaisers, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alfentanil; Fentanyl; Morphine; Piritramide; Remifentanil; Sufentanil

Indexed keywords

ALFENTANIL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; CONTRAST MEDIUM; CREATININE; DRUG METABOLITE; FENTANYL; KIDNEY ENZYME; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PIRITRAMIDE; REMIFENTANIL; SUFENTANIL; NARCOTIC ANALGESIC AGENT;

CREATININE BLOOD LEVEL; DRUG CHOICE; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG HYDROLYSIS; DRUG INFUSION; DRUG METABOLISM; DRUG USE; HUMAN; INTRAVENOUS ANESTHESIA; KIDNEY FAILURE; KIDNEY METABOLISM; LIVER FAILURE; LIVER METABOLISM; PATHOPHYSIOLOGY; PLASMA CLEARANCE; REVIEW; RISK FACTOR; ANESTHESIA; LIVER FUNCTION TEST; METABOLISM;

ANALGESICS, OPIOID; ANESTHESIA; HUMANS; KIDNEY FAILURE; LIVER FAILURE; LIVER FUNCTION TESTS;

EID: 1842482663     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-004-0651-y     Document Type: Review

References (44)

1. Aitkenhead AR, Vater M, Achola K et al. (1984) Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure. Br J Anaesth 56:813-819
2. Aronson S (2000) Renal function monitoring. In: Miller RD (ed) Anesthesia, 5th edn. Churchill, Livingstone, pp 1296-1297
3. Bailey PL, Egan TD, Stanley TH (2000) Intravenous opioid anesthetics. In: Miller RD (ed) Anesthesia, 5th edn. Churchill, Livingstone, pp 310-316
4. Bergasa NV, Rothman RB, Mukerjee E et al. (2002) Upregulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure. Life Sci 22:1701-1708
5. Blaschke TF (1977) Protein binding and kinetics of drugs in liver diseases. Clin Pharmacokinet 2:32-44
6. Bovill JG, Sebel PS, Blackburn CL, Heykants J (1982) The pharmacokinetics of alfentanil (R39209): a new opioid analgesic. Anesthesiology 57:439-443
7. Bovill JG, Sebel PS, Blackburn CL et al. (1984) The pharmacokinetics of sufentanil in surgical patients. Anesthesiology 61:502-506
8. Bower S, Sear JW, Roy RC, Carter RF (1992) Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients. Br J Anaesth 68:462-465
9. Chauvin M, Lebrault C, Levron JC, Duvaldestin P (1987) Pharmacokinetics of alfentanil in chronic renal failure. Anesth Analg 66:53-56
10. Chauvin M, Ferrier C, Haberer JP et al. (1989) Sufentanil pharmacokinetics in patients with cirrhosis. Anesth Analg 68:1-4
11. Child CG, Turcotte JG (1964) Surgery and portal hypertension. Major Probl Clin Surg 1:1-85
12. Coral IM, Moore AR, Strunin L (1980) Plasma concentrations of fentanyl in normal surgical patients with severe renal failure. Br J Anesth 52:101-108
13. Davis G, Kingswood C, Street M (1996) Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 31:410-422
14. Del Olmo JA, Flor-Lorente B, Flor-Civera B et al. (2003) Risk factors for nonhepatic surgery in patients with cirrhosis. World J Surg 13 [epub ahead of print]
15. Dershwitz M, Hoke JF, Rosow CE et al. (1996) Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 84:812-820
16. Egan TD, Lemmens HJ, Fiset P et al. (1993) The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79:881-892
17. Fahmy NR (1984) Sufentanil: a review. In: Estafanous FG (ed) Opioids in anesthesia. Butterworth, Boston, pp 132-139
18. Ferrier C, Marty J, Bouffard Y, Haberer J et al. (1985) Alfentanil pharmacokinetics in patients with cirrhosis. Anesthesiology 62:480-484
19. George J, Murray M, Byth K, Farrell GC (1995) Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 21:120-128
20. Glass PS, Gan TJ, Howell S (1999) A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 89:57-14
21. Haas CE, Kaufman DC, Jones CE et al. (2003) Cytochrome P450 3A4 activity after surgical stress. Crit Care Med 31:1338-1346
22. Haberer JP, Schoeffler P, Couderc E, Duvaldestin P (1982) Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth 54:1267-1270
23. Hasselstrom J, Eriksson S, Fersson A et al. (1990) The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol 29:289-297
24. Hoke JF, Shlugman D, Derschwitz M et al. (1997) Pharmacokinetics anesthesiologists, and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 87:533-541
25. Janicki PK, James MF, Erskine WA (1992) Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro. Br J Anaesth 68:311-312
26. Kietzmann D, Briede I, Bouilion T et al. (1996) Pharmacokinetics of piritramide after an intravenous bolus in surgical patients. Acta Anaesthesiol Scand 40:898-903
27. Koehntop DE, Noormohamed SE, Fletcher CV (1994) Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation. Pharmacotherapy 14:592-599
28. Lemmens HJ, Burm AG, Bovill JG et al. (1992) Pharmacodynamics of alfentanil. The role of plasma protein binding. Anesthesiology 76:65-70
29. Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Annu Rev Med 39:465-490
30. Lötsch J, Geisslinger G, Tegeder I (2001) Opioide bei Leber-oder Nierenfunktionsstörung. In: Zenz M, Jurna I (Hrsg) Lehrbuch der Schmerztherapie. WVG, Stuttgart, S 329-342
31. Murphy MR, Hug CC Jr, McClain DA (1983) Dose-independent pharmacokinetics of fentanyl. Anesthesiology 59:537-540
32. Osborn R, Joel S, Grebenik K et al. (1993) The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther 54:158-167
33. Patwardhan RV, Johnson RF, Hoyumpa A Jr et al. (1981) Normal metabolism of morphine in cirrhosis. Gastroenterology 81:1006-1011
34. Pauli-Magnus C, Hofmann U, Mikus G et al. (1999) Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambolatory peritoneal dialysis. Nephrol Dial Transplant 14:903-909
35. Pugh RN, Murray-Lyon IM, Dawson, JL (1973) Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60:646-649
36. Roizen MF (2000) Anesthetic implications of concurrent diseases. In: Miller RD (ed) Anesthesia, 5th edn. Churchill, Livingstone, pp 974-977
37. Ross A, Glass P (1997) Atlas of anesthesia: scientific principles of anesthesia. Current medicine
38. Scholz J, Steinfath M (2001) Analgetika. In: Kochs E, Krier C, Buzello W, Adams HA (Hrsg) Anästhesiologie, 1. Ausgabe. Thieme, Stuttgart New Yok, S 236
39. Sear JW (1989) Sufentanil disposition in patients undergoing renal transplantation: influence of choice of kidney model. Br J Anesth 63:60-67
40. Shusterman N, Strom BL, Murray TG et al. (1987) Risk factors and outcome of hospital acquired acute renal failure: clinical epidemiology study. Am J Med 83:65-71
41. Stanski DR, Hug CC Jr (1982) Alfentanil - a kinetically predictable narcotic analgesic. Anesthesiology 57:435-438
42. Tverskoy M, Gelman S, Fowler KC, Bradley EL (1985) Influence of fentanyl and morphine on intestinal circulation. Anesth Analg 64:577-584
43. Wiggum DC, Cork RC, Weldon ST et al. (1985) Postoperative respiratory depression and elevated sufentanil levels in a patient with chronic renal failure. Anesthesiology 63:708-710
44. Yun CH, Wood M, Wood AJ, Guengerich FP (1992) Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance. Anesthesiology 77:467-474